Submissions for variant NM_000086.2(CLN3):c.1210C>A (p.His404Asn) (rs146610181)

Total submissions: 7

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
GeneDx	RCV000116748	SCV000167746	benign	not specified	2013-10-22	criteria provided, single submitter	clinical testing	This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics	RCV000223968	SCV000280830	likely benign	not provided	2015-04-13	criteria provided, single submitter	clinical testing	Converted during submission to Likely benign.
Invitae	RCV000229400	SCV000285809	benign	Neuronal ceroid lipofuscinosis	2018-01-03	criteria provided, single submitter	clinical testing
Illumina Clinical Services Laboratory,Illumina	RCV000274494	SCV000396319	uncertain significance	Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive	2016-06-14	criteria provided, single submitter	clinical testing
Ambry Genetics	RCV000717295	SCV000848144	benign	Seizures	2016-06-24	criteria provided, single submitter	clinical testing	Lines of evidence used in support of classification: General population or sub-population frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance
Genetic Services Laboratory, University of Chicago	RCV000116748	SCV000150722	likely benign	not specified		no assertion criteria provided	clinical testing	Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.
Mayo Clinic Genetic Testing Laboratories,Mayo Clinic	RCV000223968	SCV000801706	likely benign	not provided	2017-02-27	no assertion criteria provided	clinical testing